Recently I am researching about IRON-OXIDE NANOPARTICLES; CARBON NANOTUBES; DRUG-DELIVERY; PEPTIDE; NANOVESICLES; STABILIZATION; NANOCARRIERS; FABRICATION; DENDRIMERS; POLYMERS, Saw an article supported by the CSIR, IndiaCouncil of Scientific & Industrial Research (CSIR) – India; UGC, IndiaUniversity Grants Commission, India; IISER Kolkata, India. SDS of cas: 99-27-4. Published in ROYAL SOC CHEMISTRY in CAMBRIDGE ,Authors: Kumar, S; Bera, S; Nandi, SK; Haldar, D. The CAS is 99-27-4. Through research, I have a further understanding and discovery of Dimethyl 5-aminoisophthalate
Porous microspheres from discotic tripeptides have been investigated as potential candidates for drug delivery vehicles. The C-3 symmetric discotic tripeptide adopts a supramolecular helical column structure by three fold intermolecular hydrogen bonding interactions as well as face to face pi-pi stacking interactions. But the C-2 symmetric discotic tripeptide adopts a supramolecular dimer like structure by six-fold intermolecular hydrogen bonding interactions and face to face pi-pi stacking interactions. Field emission scanning electron microscopy (FE-SEM) revealed that the C-3 symmetric discotic tripeptide exhibits bird nest-like porous microsphere morphology formed by the assembly of the individual columns. However the C-2 symmetric discotic tripeptide forms round clay pitcher like porous microspheres. These porous microspheres have been used as potential carriers for the sustained release of a bacteriostatic antibiotic sulfamethoxazole. The spectroscopic studies as well as the growth inhibition of E. coli reveal that the round clay pitcher-like porous microspheres are more efficient than the bird nest-like porous microspheres for the sustained release of drugs. The report highlights the importance of the self-assembly pattern for the fabrication of advanced functional materials.
SDS of cas: 99-27-4. About Dimethyl 5-aminoisophthalate, If you have any questions, you can contact Kumar, S; Bera, S; Nandi, SK; Haldar, D or concate me.
Reference:
Patent; ASTRA ZENECA AB; NPS PHARMACEUTICALS, INC.; WO2004/14881; (2004); A2;,
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics